What is S&V Labs?
S&V Labs operates as a sophisticated, full-service manufacturer specializing in personal and home care product development. With a legacy spanning 37 years, the company distinguishes itself through a blend of proprietary R&D, sustainable liposome technology, and comprehensive turnkey manufacturing services. By offering end-to-end solutions—from initial formulation and brand positioning to final shelf-ready production—S&V Labs serves as a critical partner for brands seeking to navigate complex market trends and sustainability benchmarks. Their expertise in effervescent technology and green chemistry positions them as a leader in the private label sector, catering to both niche startups and established retail entities.
How much funding has S&V Labs raised?
S&V Labs has raised a total of $50M across 1 funding round:
Debt
$50M
Debt (2023): $50M with participation from Abacus Finance Group
Key Investors in S&V Labs
Abacus Finance Group
Abacus Finance is a New York City-based lender specializing in tailored credit solutions for private equity-backed lower-middle market companies. They emphasize speed and flexibility in providing senior credit facilities to support corporate growth and buyout financing.
What's next for S&V Labs?
The recent capital allocation is expected to catalyze S&V Labs' expansion into advanced manufacturing capabilities and further investment in sustainable R&D. By leveraging this financing, the company is well-positioned to scale its replenishment systems and enhance its ROI-focused service offerings. As the firm continues to refine its liposome technology and broaden its portfolio, the focus will likely shift toward optimizing supply chain efficiencies and deepening its penetration into the premium skincare and home care markets. This strategic growth phase will be defined by a commitment to maintaining high-quality standards while meeting the increasing demand for eco-conscious, market-ready consumer goods.
See full S&V Labs company page
